Wednesday, December 16, 2020

Carlsmed Picks Up $10M For Spinal Correction Devices

San Diego-based Carlsmed, a biotech startup developing spine deformity correction devices, has raised $10M in a Series A funding. The funding was led by U.S. Venture Partners, and also included The Vertical Group, Cove Fund, and Wavemaker Three-Sixty Health, among others. According to the company, the funding will go to commercialize the company's family of aprevo spine deformity correction devices. The startup is led by CEO Mike Cordonnier. As part of the funding, it has added USVP's Jonathan Root, USVP's Phil Young, and Kevin Sidow, past CEO of St. Francis Medical Technologies and Moximed, to its board of directors.